Target intelligence / Profile preview

Regenerating islet-derived protein 3-gamma (REG3G)

Target
REG3G
Molecular classification
C-type lectin, Antimicrobial peptide, Secreted protein, Other
01

Overview

Regenerating islet-derived protein 3-gamma (REG3G) is a secreted C-type lectin with a carbohydrate recognition domain, primarily expressed in the intestine and other mucosal tissues[1][2][3]. REG3G binds to peptidoglycan on the surface of Gram-positive bacteria, exerting direct bactericidal activity to help maintain the mucosal barrier and modulate host-microbiota interactions[1][2][3][4]. It is induced in intestinal tissues after microbial colonization or infection and plays a protective role in mucosal immunity. Beyond its antimicrobial action, REG3G is involved in regulation of inflammation and tissue regeneration, with evidence pointing to roles in diseases such as pancreatitis, inflammatory bowel conditions, certain infections, and possibly some cancers and inflammatory heart conditions[1][3]. No approved drugs directly target REG3G, but expression is altered in response to various inflammatory and microbiota-altering interventions[3].

Other names
Regenerating family member 3 gammaRegenerating islet-derived protein 3-gamma 16.5 kDa formRegenerating islet-derived protein 3-gamma 15 kDa formRegenerating islet-derived protein III-gammaREG IIIREG-3-gammaREG-IIIPAP1BPAP-1BPAP IBPAPIBLPPM429UNQ429Pancreatitis-associated protein 1BPancreatitis-associated protein IBReg III-gammaregenerating gene III
02

Biological functions

Innate immunityAntimicrobial activityCarbohydrate bindingRegulation of inflammationMaintenance of gut barrierTissue regeneration
03

Disease associations

InflammationInfectionPancreatitisCancerCardiac sarcoidosisOther
04

Safety considerations

Possible issues with immune modulation; therapeutic manipulation may influence microbiota composition or mucosal immunity but specific clinical safety concerns have not been widely documented
05

Biomarkers

Potential biomarker for inflammatory bowel disease, pancreatitis, and other mucosal inflammatory states

Beyond the preview

Go deeper on Regenerating islet-derived protein 3-gamma (REG3G).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenerating islet-derived protein 3-gamma (REG3G).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call